NCT05128032View on ClinicalTrials.gov

Pressure-enabled Delivery in Radioembolization (TriNav Study)

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions
Liver CancerHepatocellular CarcinomaMetastatic Colorectal Cancer
Interventions
DEVICE

Standard microcatheter

Small device used for mapping as part of radioembolization procedure

DEVICE

PEDD device

Pressure enabled small device used for mapping as part of radioembolization procedure

Trial Locations (2)

02114

Massachusetts General Hospital Cancer Center, Boston

02245

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

TriSalus Life Sciences, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER